MD
Hector MacLean Distinguished Professorship in Cancer Research
Radiation Oncology
UNC-Chapel Hill
Clinical Research
Gastrointestinal Oncology Program
Bone and Soft Tissue Oncology Program
Area of interest
I am in involved in clinical and translational research, primarily in gastrointestinal cancers and also in nanotechnology. I work with laboratory scientists to help advance clinical research and bring new ideas from the laboratory to clinical fruition. I have been interested in radiation sensitizers in the treatment of rectal cancer as well as combined modality therapy for many diseases in the GI track.
Awards and Honors
- Gold Medal- American Society for Therapeutic Radiology
- American Society of Clinical Oncology – Board of Directors
- UNC- Berryhill Lecturer
- Past-President and Past-Chairman of the Board- American Society for Therapeutic Radiology and Oncology (ASTRO)
- Gold Medal- ASTRO
- Steering Committee- ASCO/ASTRO/AGA/SSO GI Oncology Conference
- Principle Investigator- UNC GI SPORE (Specialized Program of Research Excellence)
- Course co-Director- AACR/ASCO Vail Workshop on Clinical Trials
- Co-chair- US GI Intergroup (GI Steering Comm)
- Co-PI on a GI Intergroup trial of adjuvant chemoradiation therapy in gastric cancer
- Paper demonstrating the value of surgical salvage in rectal cancer in a large Intergroup clinical trial cohort- to be published in the Journal of Clinical Oncology
- Demonstration of the importance of sub staging of rectal cancer for individualization of adjuvant therapy
- Early phase studies defining the ability to combine various agents (farnesyl transferase inhibitors, gemcitabine, oxaliplatin) with radiation therapy in various tumor types
- Design of new radiation parameters for adjuvant treatment of gastric cancer and its implementation in the new Intergroup gastric adjuvant trial
